Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,220 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07373834Recruiting
Tirzepatide and muscle health in women with obesity
This study tests whether tirzepatide, a medication for weight management, affects muscle health in women with obesity. It may help if you are looking for a treatment that preserves muscle while losing weight.
LjubljanaAges 18–50 - NCT07374354Recruiting
Pain and anxiety control for kids with MIH
This study tests a pain-relieving medicine given before dental treatment to see if it helps reduce pain and anxiety in children with molar incisor hypomineralization (MIH), a condition that causes weak enamel on molars and front teeth.
GizaAges 6–12 - NCT07374562Recruiting
Nerve block for Long COVID symptoms
This study tests a nerve block injection (called a stellate ganglion block) to see if it can help relieve ongoing symptoms of Long COVID, especially breathing problems. It is for people who have had COVID-19 symptoms for at least 3 months.
Trois-Rivières, QuebecAges 18 years+ - NCT07374471RecruitingPhase 1/Phase 2
Testing MB-001 for moderate to severe ulcerative colitis
This study tests an investigational drug called MB-001 for people with moderate to severe ulcerative colitis who have already tried standard treatments without success. It aims to see if the drug is safe and helps control inflammation.
ChisinauAges 18–75 - NCT07375758RecruitingPhase 1/Phase 2
Testing MIL116 in healthy people and those with IgA Nephropathy
This study tests a new drug called MIL116 for IgA Nephropathy. First, healthy volunteers will test the drug's safety, then people with IgA Nephropathy will see if it can help reduce protein in their urine.
BeijingAges 18 years+ - NCT07376200RecruitingPhase 1
First-in-human study of a new injection (HEC-151)
This study tests a new injection called HEC-151 in healthy men to see how it affects the body at different single doses. It's one of the first steps to see if the drug is safe and could one day help people with diabetes or related conditions.
Chongqing, BishanAges 18–45 - NCT07377032RecruitingPhase 3
L-serine for GRIN-related neurodevelopmental disorders
This trial tests whether an amino acid supplement called L-serine can help people with GRIN-related neurodevelopmental disorders. These disorders are caused by specific genetic changes that affect brain function, and the study aims to see if L-serine can improve symptoms.
LyonAges 2–30 - NCT07377396RecruitingPhase 1
Safety study of ARGX-124 in healthy volunteers
This trial tests a new drug called ARGX-124 in healthy people to see if it is safe. It is a first step before testing it in patients with certain conditions.
MontrealAges 18–65 - NCT07377539RecruitingPhase 1
A study of JZP047 in healthy volunteers
This study tests a new investigational drug called JZP047 in healthy volunteers. Researchers want to see how safe it is, how the body processes it, and whether taking it with food changes its effects.
Lincoln, NebraskaAges 18–55 - NCT07378527RecruitingPhase 2/Phase 3
Study of ICP-332 for chronic hives not helped by antihistamines
This trial tests an experimental drug called ICP-332 for people with chronic spontaneous urticaria (long-term hives) that is not well controlled by standard antihistamines. The goal is to see if the drug is safe and effective at reducing hives.
Bengbu, AnhuiAges 18–75 - NCT07379216Recruiting
Vitamin C and glutathione drink for skin health
This study tests a liquid supplement containing vitamin C and glutathione to see if it benefits skin health. It may be a good fit if you are a healthy adult looking to improve your skin without using other skin products during the study.
Pingtung CityAges 18–65 - NCT07379333RecruitingPhase 3
Testing a new drug for type 2 diabetes when metformin and dapagliflozin aren't enough
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
Gyeonggi-doAges 19 years+ - NCT07379580RecruitingPhase 2
Test of an mRNA vaccine for mpox in Africa
This trial tests a new mRNA vaccine to prevent mpox. It looks at how safe and effective the vaccine is in adults who have or haven't been exposed to mpox or similar viruses before.
KinshasaAges 18–64 - NCT07380412Recruiting
Supplement study for ADHD med side effects
This trial tests if a dietary supplement can help reduce common side effects of stimulant medications for ADHD, like trouble sleeping or feeling irritable. If you take a stable dose of ADHD medication and are dealing with these issues, you may be able to join.
Las Vegas, NevadaAges 18–55 - NCT07381374Recruiting
Fecal transplant for children with autism
This trial tests whether fecal microbiota transplantation can help children with moderate-to-severe autism. It involves giving healthy donor bacteria to improve gut health and possibly autism symptoms.
Shenzhen, GuangdongAges 3–16 - NCT07387094RecruitingPhase 3
A study of XW003 for obesity with sleep apnea (no CPAP)
This trial tests an investigational weekly injection called XW003 for weight loss in people who have obesity and moderate-to-severe sleep apnea but do not use a CPAP machine. It aims to see if the drug can help with weight loss and improve sleep apnea without the need for a breathing machine.
Beijing, Beijing MunicipalityAges 18–75 - NCT07387198RecruitingPhase 2
Testing cemiplimab before surgery for Merkel cell carcinoma
This trial tests whether giving the immunotherapy drug cemiplimab before surgery can improve outcomes for people with stage I or II Merkel cell carcinoma. If you qualify, you would receive cemiplimab before your sentinel lymph node biopsy.
Heidelberg, Baden-WurttembergAges 18 years+ - NCT07387900RecruitingPhase 2
Metformin for preventing cancer in oral leukoplakia
This study tests if metformin — a medication commonly used for diabetes — can prevent oral leukoplakia from turning into cancer when applied as a mouth rinse and taken as a pill. It is for people with non-severe white patches in the mouth.
CairoAges 21 years+ - NCT07390123RecruitingPhase 3
Study of HSK39297 for IgA Nephropathy (IgAN)
This trial tests an experimental tablet, HSK39297, for people with IgA nephropathy, a kidney disease. It aims to see if the drug is safe and can help reduce protein in the urine, which is a sign of kidney damage.
Huangshan City, AnhuiAges 18 years+ - NCT07390552RecruitingPhase 2
Study of PLH-2301 for muscle loss in older adults
This trial tests an experimental medicine called PLH-2301 to see if it can help improve muscle strength and function in people with age-related muscle loss (sarcopenia). It may be an option if you are 65 or older, have been diagnosed with sarcopenia, and can walk on your own.
Seongnam-si, Gyeonggi-doAges 65 years+ - NCT07391306RecruitingPhase 2/Phase 3
New treatment for interstitial cystitis without Hunner's lesions
This trial is testing a new treatment for people with painful bladder syndrome (interstitial cystitis) who do not have Hunner's lesions in their bladder. It aims to see if the treatment can help reduce pelvic pain and frequent urination.
MoscowAges 18–65 - NCT07391579RecruitingPhase 4
Daily Cialis Plus On-Demand Viagra for Hard-to-Treat ED
This trial tests if taking one Cialis pill daily and a Viagra pill only when needed works better for men who have tried ED pills before but they didn't help. It aims to find a new way to help men who haven't responded to standard ED treatments.
Al Mansurah, Dakahlia GovernorateAges 21 years+ - NCT07392723RecruitingPhase 2
Flaxseed nutrition to protect memory in APOE4 adults
This study tests a special flaxseed-based nutrition drink to see if it can slow memory loss in older adults who have the APOE4 gene and mild cognitive impairment (early memory trouble). If you qualify, you'll take the drink daily for a year and have memory tests and brain scans.
New Brunswick, New JerseyAges 60 years+ - NCT07393126Recruiting
A trial of a supplement for mild urinary urgency in healthy Japanese adults
This study tests a product designed to support urinary health. The goal is to see if it helps reduce frequent urination and urgency in healthy Japanese adults who have mild bladder symptoms.
Nerima-ku, TokyoAges 18 years+
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,220 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.